The Relationship Between Family History of Depression and Brain Structure and Function: A Systematic Review of Large Cohorts.

Biol PsychiatryJan 15, 2026 (epub)
Clinical ResearchPsychiatryOpen access

James O Woodruff, Tenzin Yangchen, Nora C Kelsall et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review identified existing longitudinal cohorts suitable for studying associations between family history of major depression and brain imaging outcomes. A structured PubMed search found 25 cohorts across 13 countries, each with at least 1,000 participants, family-history and psychiatric measures, and at least one MRI collection. Across published studies, familial risk was most often associated with alterations in subcortical regions, particularly the striatum and amygdala, and cortical regions including the anterior cingulate and prefrontal cortex. Evidence that these brain differences predict later psychopathology remains limited.

Key findings

  • The review identified 25 eligible longitudinal cohorts in 13 countries, each with ≥1000 participants and at least one MRI collection.
  • Reported associations with familial risk most frequently involved the striatum, amygdala, anterior cingulate, and prefrontal cortex.
  • Evidence that the identified brain regions predict subsequent psychopathology was limited.

Why it matters

Studying symptom-free people with familial risk may help distinguish brain features associated with susceptibility from changes related to having depression. The review also points to existing large cohorts as a resource for investigating these questions over time, while underscoring that the clinical significance of reported imaging associations is not yet established.

What to keep in mind

The review reports that evidence linking the identified brain regions to later psychopathology is limited; long-term implications remain unclear.

Source

Published in Biol Psychiatry. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.